D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Kornit Digital
KRNT
$695M
| $2.75M | ﹤0.01% |
115,686
+55,223
| +91% | +$1.17M |
|
1902
iShares Russell 2000 ETF
IWM
$80.2B
| $2.74M | ﹤0.01% |
17,919
| – | – |
|
1903
PUT
ScottsMiracle-Gro
SMG
$3.97B
| $2.74M | ﹤0.01% |
34,900
-14,500
| -29% | -$1.09M |
|
1904
Titan International
TWI
$475M
| $2.74M | ﹤0.01% |
459,029
+70,675
| +18% | +$398K |
|
1905
PUT
Ligand Pharmaceuticals
LGND
$5.94B
| $2.74M | ﹤0.01% |
34,945
+6,251
| +22% | +$474K |
|
1906
CBRE Group
CBRE
$43.3B
| $2.73M | ﹤0.01% |
55,156
-202,532
| -79% | -$9.51M |
|
1907
PUT
Ulta Beauty
ULTA
$22.2B
| $2.72M | ﹤0.01% |
7,800
-40,000
| -84% | -$12.1M |
|
|
TSE
1908
DELISTED
Trinseo
TSE
| $2.71M | ﹤0.01% |
59,914
+10,053
| +20% | +$487K |
|
|
NPKI
1909
NPK International
NPKI
$1.06B
| $2.71M | ﹤0.01% |
296,064
-13,510
| -4% | -$116K |
|
|
KEYW
1910
DELISTED
The KEYW Holding Corporation
KEYW
| $2.7M | ﹤0.01% |
313,236
+105,448
| +51% | +$767K |
|
|
LKFT
1911
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
| $2.7M | ﹤0.01% |
22,899
+3,806
| +20% | +$384K |
|
1912
Koppers
KOP
$942M
| $2.69M | ﹤0.01% |
103,651
-53,341
| -34% | -$1.25M |
|
|
AVLR
1913
DELISTED
Avalara, Inc.
AVLR
| $2.69M | ﹤0.01% |
48,272
+41,658
| +630% | +$1.93M |
|
1914
Silgan Holdings
SLGN
$4.34B
| $2.69M | ﹤0.01% |
90,856
-124,813
| -58% | -$3.44M |
|
1915
CALL
Eaton
ETN
$150B
| $2.69M | ﹤0.01% |
+33,400
| New | +$2.55M |
|
|
ARGO
1916
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.69M | ﹤0.01% |
38,084
-32,549
| -46% | -$2.21M |
|
1917
PUT
lululemon athletica
LULU
$13.6B
| $2.69M | ﹤0.01% |
16,400
-80,700
| -83% | -$11.8M |
|
|
MTSC
1918
DELISTED
MTS Systems Corp
MTSC
| $2.69M | ﹤0.01% |
49,314
-11,465
| -19% | -$582K |
|
1919
PUT
State Street
STT
$50.2B
| $2.69M | ﹤0.01% |
40,800
-50,100
| -55% | -$3.47M |
|
|
XLNX
1920
CALL
DELISTED
Xilinx Inc
XLNX
| $2.67M | ﹤0.01% |
+21,100
| New | +$2.37M |
|
|
DHC
1921
Diversified Healthcare Trust
DHC
$2.17B
| $2.67M | ﹤0.01% |
226,982
-1,120,985
| -83% | -$14.4M |
|
1922
Carter's
CRI
$1.39B
| $2.67M | ﹤0.01% |
26,446
-22,378
| -46% | -$2M |
|
1923
ADT
ADT
$5.51B
| $2.66M | ﹤0.01% |
415,928
+261,911
| +170% | +$1.89M |
|
|
CSW
1924
CSW Industrials
CSW
$5.11B
| $2.65M | ﹤0.01% |
46,341
+6,012
| +15% | +$325K |
|
|
ACHN
1925
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.65M | ﹤0.01% |
896,796
+441,973
| +97% | +$1.09M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.